Oxycodeinone en es it fr


Oxycodeinone Marchi, Oxycodeinone Analoghi

Oxycodeinone Marchi miscela

  • Combunox
  • Percodan-Demi (Acetylsalicylic Acid + Oxycodone Hydrochloride)
  • Pms-Oxycodone - Acetaminophen (Acetaminophen + Oxycodone (Oxycodone Hydrochloride))
  • Rivacocet (Acetaminophen + Oxycodone (Oxycodone Hydrochloride))
  • Roxicet Tab (Acetaminophen + Oxycodone Hydrochloride)
  • Oxycodeinone Formula chimica


    Oxycodeinone RX link


    Oxycodeinone FDA foglio

    Oxycodeinone FDA

    Oxycodeinone DMS (foglio di materiale di sicurezza)

    Oxycodeinone MSDS

    Oxycodeinone Sintesi di riferimento

    Piccolo, Lutz "Chimica degli alcaloidi dell'oppio",, Suppl.No.103 (1932)

    Oxycodeinone Peso molecolare

    315.364 g/mol

    Oxycodeinone Temperatura di fusione

    218-220 oC

    Oxycodeinone H2O Solubilita

    100 mg / ml

    Oxycodeinone Stato


    Oxycodeinone LogP


    Oxycodeinone Forme di dosaggio

    Tablet; Supposta

    Oxycodeinone Indicazione

    Per il trattamento della diarrea, edema polmonare; Per il sollievo del dolore da moderato a moderatamente grave

    Oxycodeinone Farmacologia

    Ossicodone, un agonista oppiaceo semisintetico derivato dalla oppiaceo alcaloide, tebaina, è simile ad altri derivati del fenantrene, come idrocodone e la morfina. L'ossicodone è disponibile in combinazione con l'aspirina o paracetamolo per il controllo del dolore e delle gambe senza riposo e sindromi Tourette.

    Oxycodeinone Assorbimento

    ben assorbita dal OxyContin compresse ® con una biodisponibilità orale del 60% al 87%

    Oxycodeinone Tossicita

    depressione respiratoria, sonnolenza procedendo a stupore o coma, flaccidità dei muscoli scheletrici, cute fredda e umida, gli alunni costretto, bradicardia, ipotensione e morte.

    Oxycodeinone Informazioni paziente


    Drug Dependence: Oxycodone can produce drug dependence of the morphine type, and therefore, has the potential for being abused. Psychic dependence, physical dependence and tolerance may develop upon repeated administration of this drug, and it should be prescribed and administered with the same degree of caution appropriate to the use of other oral narcotic-containing medications. Like other narcotic-containing medications, this drug is subject to the Federal Controlled Substances Act.

    Usage in Ambulatory Patients: Oxycodone may impair the mental and/or physical abilities required for the performance of potentially hazardous tasks such as driving a car or operating machinery. The patient using this drug should be cautioned accordingly.

    Interaction with Other Central Nervous System Depressants: Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, other tranquilizers, sedative-hypnotics or other CNS depressants (including alcohol) concomitantly with oxycodone hydrochloride may exhibit an additive CNS depression. When such combined therapy is contemplated, the dose of one or both agents should be reduced.

    Usage in Pregnancy: Safe use in pregnancy has not been established relative to possible adverse effects on fetal development. Therefore, this drug should not be used in pregnant women unless, in the judgment of the physician, the potential benefits outweigh the possible hazards.

    Usage in Children: This drug should not be administered to children.


    Head Injury and Increased Intracranial Pressure: The respiratory depressant effects of narcotics and their capacity to elevate cerebrospinal fluid pressure may be markedly exaggerated in the presence of head injury, other intracranial lesions or a pre-existing increase in intracranial pressure. Furthermore, narcotics produce adverse reactions which may obscure the clinical course of patients with head injuries.

    Acute Abdominal Conditions: The administration of this drug or other narcotics may obscure the diagnosis or clinical course in patients with acute abdominal conditions.

    Special Risk Patients: This drug should be given with caution to certain patients such as the elderly, or debilitated, and those with severe impairment of hepatic or renal function, hypothyroidism, Addison's disease and prostatic hypertrophy or urethral stricture.

    Oxycodeinone Atto interessato organismi

    Gli esseri umani e altri mammiferi